High CD47 expression in MF correlates with worse outcomes [15]; CTCL tumors with higher CD47 levels have been shown to grow more rapidly and aggressively than their CD47 KO counterparts [15]. The gene discussed is CD47; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.